Total Xenoestrogen Body Burden in Relation to Mammographic Density, a Marker of Breast Cancer Rlisk

Breast Cancer Risk Clinical Trial

Official title:
Total Xenoestrogen Body Burden in Relation to Mammographic Density, a Marker of Breast Cancer Risk

Status Completed

Clinical Trial Summary

Mammographic density is sensitive to estorgen exposure and constitutes a strong intermediate maker of breast cancer risk. We hypothesize that women with higher serum xenoestrogen levels will have greater mammographic density.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT00839696
Study type	Observational
Source	University of Wisconsin, Madison
Contact
Status	Completed
Phase
Start date	July 2008
Completion date	April 2010

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT03688204` - Clinical Implementation of a Polygenic Risk Score (PRS) for Breast Cancer
Active, not recruiting	`NCT04082117` - Uptake of Genetic Counseling Among African American Women	N/A
Completed	`NCT05082740` - FH-Risk 2.0: Updating Breast Cancer Risk Estimates
Not yet recruiting	`NCT05848856` - The RISC Registry--Risk Informed Screening Registry
Recruiting	`NCT04248257` - Peer Support For Young Adult Women With High Breast Cancer Risk	N/A
Enrolling by invitation	`NCT04265547` - Family-Based Intervention Study of the Effects of Environmental Exposures on Breast Tissue Composition	N/A
Completed	`NCT01511276` - The Effects of Equivalent Weight Loss With or Without Exercise Training on Breast Cancer Risk (SHAPE-2)	N/A
Completed	`NCT00555386` - Soy, Selenium and Breast Cancer Risk	N/A